Literature DB >> 21115742

miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1.

Jonathon D Roybal1, Yi Zang, Young-Ho Ahn, Yanan Yang, Don L Gibbons, Brandi N Baird, Cristina Alvarez, Nishan Thilaganathan, Diane D Liu, Pierre Saintigny, John V Heymach, Chad J Creighton, Jonathan M Kurie.   

Abstract

The microRNA-200 (miR-200) family is part of a gene expression signature that predicts poor prognosis in lung cancer patients. In a mouse model of K-ras/p53-mutant lung adenocarcinoma, miR-200 levels are suppressed in metastasis-prone tumor cells, and forced miR-200 expression inhibits tumor growth and metastasis, but the miR-200 target genes that drive lung tumorigenesis have not been fully elucidated. Here, we scanned the genome for putative miR-200 binding sites and found them in the 3'-untranslated region (3'-UTR) of 35 genes that are amplified in human cancer. Mining of a database of resected human lung adenocarcinomas revealed that the levels of one of these genes, Flt1/VEGFR1, correlate inversely with duration of survival. Forced miR-200 expression suppressed Flt1 levels in metastasis-prone lung adenocarcinoma cells derived from K-ras/p53-mutant mice, and negatively regulated the Flt1 3'-UTR in reporter assays. Cancer-associated fibroblasts (CAFs) isolated from murine lung adenocarcinomas secreted abundant VEGF and enhanced tumor cell invasion in coculture studies. CAF-induced tumor cell invasion was abrogated by VEGF neutralization or Flt1 knockdown in tumor cells. Flt1 knockdown decreased the growth and metastasis of tumor cells in syngeneic mice. We conclude that miR-200 suppresses lung tumorigenesis by targeting Flt1. ©2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21115742      PMCID: PMC3232024          DOI: 10.1158/1541-7786.MCR-10-0497

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  44 in total

1.  Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

Authors:  E L Jackson; N Willis; K Mercer; R T Bronson; D Crowley; R Montoya; T Jacks; D A Tuveson
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

2.  Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF.

Authors:  Shadan Ali; Aamir Ahmad; Sanjeev Banerjee; Subhash Padhye; Kristin Dominiak; Jacqueline M Schaffert; Zhiwei Wang; Philip A Philip; Fazlul H Sarkar
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

Review 3.  Thy-1, a versatile modulator of signaling affecting cellular adhesion, proliferation, survival, and cytokine/growth factor responses.

Authors:  Tanya A Rege; James S Hagood
Journal:  Biochim Biophys Acta       Date:  2006-08-18

4.  Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants.

Authors:  H Gille; J Kowalski; B Li; J LeCouter; B Moffat; T F Zioncheck; N Pelletier; N Ferrara
Journal:  J Biol Chem       Date:  2000-10-31       Impact factor: 5.157

5.  The differential effects of mutant p53 alleles on advanced murine lung cancer.

Authors:  Erica L Jackson; Kenneth P Olive; David A Tuveson; Roderick Bronson; Denise Crowley; Michael Brown; Tyler Jacks
Journal:  Cancer Res       Date:  2005-11-15       Impact factor: 12.701

6.  Isolation of Cry1Ab protein mutants of Bacillus thuringiensis by a highly efficient PCR site-directed mutagenesis system.

Authors:  R Meza; M E Nuñez-Valdez; J Sanchez; A Bravo
Journal:  FEMS Microbiol Lett       Date:  1996-12-15       Impact factor: 2.742

7.  Conserved MicroRNA miR-8/miR-200 and its target USH/FOG2 control growth by regulating PI3K.

Authors:  Seogang Hyun; Jung Hyun Lee; Hua Jin; JinWu Nam; Bumjin Namkoong; Gina Lee; Jongkyeong Chung; V Narry Kim
Journal:  Cell       Date:  2009-12-11       Impact factor: 41.582

Review 8.  Altered macrophage differentiation and immune dysfunction in tumor development.

Authors:  Antonio Sica; Vincenzo Bronte
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

Review 9.  MicroRNAs: Crucial multi-tasking components in the complex circuitry of tumor metastasis.

Authors:  Scott Valastyan; Robert A Weinberg
Journal:  Cell Cycle       Date:  2009-11-13       Impact factor: 4.534

10.  Expression signatures of metastatic capacity in a genetic mouse model of lung adenocarcinoma.

Authors:  Don L Gibbons; Wei Lin; Chad J Creighton; Shuling Zheng; Dror Berel; Yanan Yang; Maria Gabriela Raso; Diane D Liu; Ignacio I Wistuba; Guillermina Lozano; Jonathan M Kurie
Journal:  PLoS One       Date:  2009-04-30       Impact factor: 3.240

View more
  85 in total

1.  MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.

Authors:  Keun Hur; Yuji Toiyama; Masanobu Takahashi; Francesc Balaguer; Takeshi Nagasaka; Junichi Koike; Hiromichi Hemmi; Minoru Koi; C Richard Boland; Ajay Goel
Journal:  Gut       Date:  2012-06-26       Impact factor: 23.059

2.  MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation.

Authors:  Lixia Guo; Jingyu Wang; Ping Yang; Qiang Lu; Ting Zhang; Yanan Yang
Journal:  IUBMB Life       Date:  2015-08-27       Impact factor: 3.885

3.  Lysyl hydroxylase 2 induces a collagen cross-link switch in tumor stroma.

Authors:  Yulong Chen; Masahiko Terajima; Yanan Yang; Li Sun; Young-Ho Ahn; Daniela Pankova; Daniel S Puperi; Takeshi Watanabe; Min P Kim; Shanda H Blackmon; Jaime Rodriguez; Hui Liu; Carmen Behrens; Ignacio I Wistuba; Rosalba Minelli; Kenneth L Scott; Johannah Sanchez-Adams; Farshid Guilak; Debananda Pati; Nishan Thilaganathan; Alan R Burns; Chad J Creighton; Elisabeth D Martinez; Tomasz Zal; K Jane Grande-Allen; Mitsuo Yamauchi; Jonathan M Kurie
Journal:  J Clin Invest       Date:  2015-02-09       Impact factor: 14.808

4.  ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism.

Authors:  Yanan Yang; Young-Ho Ahn; Yulong Chen; Xiaochao Tan; Lixia Guo; Don L Gibbons; Christin Ungewiss; David H Peng; Xin Liu; Steven H Lin; Nishan Thilaganathan; Ignacio I Wistuba; Jaime Rodriguez-Canales; Georgia McLendon; Chad J Creighton; Jonathan M Kurie
Journal:  J Clin Invest       Date:  2014-04-24       Impact factor: 14.808

5.  MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility.

Authors:  Liang Zhu; Huarong Chen; Donger Zhou; Dan Li; Rui Bai; Shu Zheng; Weiting Ge
Journal:  Med Oncol       Date:  2011-05-12       Impact factor: 3.064

Review 6.  MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment.

Authors:  F J Kohlhapp; A K Mitra; E Lengyel; M E Peter
Journal:  Oncogene       Date:  2015-04-13       Impact factor: 9.867

7.  Unveiling the principle of microRNA-mediated redundancy in cellular pathway regulation.

Authors:  Simon Fischer; René Handrick; Armaz Aschrafi; Kerstin Otte
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

8.  Identification of lymph node metastasis-related microRNAs in lung adenocarcinoma and analysis of the underlying mechanisms using a bioinformatics approach.

Authors:  Li Yan; Demin Jiao; Huizhen Hu; Jian Wang; Xiali Tang; Jun Chen; Qingyong Chen
Journal:  Exp Biol Med (Maywood)       Date:  2016-11-14

Review 9.  The microRNA networks of TGFβ signaling in cancer.

Authors:  V P Sivadas; S Kannan
Journal:  Tumour Biol       Date:  2013-12-10

Review 10.  microRNA-200b as a Switch for Inducible Adult Angiogenesis.

Authors:  Mithun Sinha; Subhadip Ghatak; Sashwati Roy; Chandan K Sen
Journal:  Antioxid Redox Signal       Date:  2015-05-10       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.